The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Several psychedelic substances. LSD, psilocybin (aka magic mushrooms), MDMA, ayahuasca and ibogaine are being studied by new drug companies to treat depression, post traumatic stress disorder, anxiety, eating disorders and alcohol and drug addiction.
Shades of Timothy Leary! 😀
This could seriously improve my retirement! Maybe I'll even get Medicare to pay for it.
RE